DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Melanoma	Q9UHD0-PRO_0000015379	map05218	tetrandrine	1794427	drug-path
ErbB signaling pathway	R-HSA-168638	map04012	tetrandrine	1794427	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	tetrandrine	1794427	drug-path
Endometrial cancer	R-HSA-2077421	map05213	tetrandrine	1794427	drug-path
Colorectal cancer	R-HSA-4791275	map05210	tetrandrine	1794427	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	tetrandrine	1794427	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	tetrandrine	1794427	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	tetrandrine	1794427	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	tetrandrine	1794427	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	tetrandrine	1794427	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	tetrandrine	1794427	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	tetrandrine	1794427	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	ozagrel	5282440	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	ozagrel	5282440	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ozagrel	5282440	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	ozagrel	5282440	drug-path
Asthma	R-HSA-444620	map05310	ozagrel	5282440	drug-path
Allograft rejection	R-HSA-9679028	map05330	ozagrel	5282440	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	ozagrel	5282440	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	ozagrel	5282440	drug-path